Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201102043 Principal Investigator: Vij, Ravi
Title: A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Refractory/Relapsed Multiple Myeloma
Description: The purpose of this research study is to learn about the safety of two anticancer drugs called carfilzomib and pegylated liposomal doxorubicin (PLD) when given together, to see what effects these drugs have on the body and on your disease, and to determine the highest safest dose of carfilzomib that...MORE
___________________________________________________________________________________________________
 Number: 201306052 Principal Investigator: Vij, Ravi
Title: Open-label, Single-arm, Phase 2 Study of the Initial and Post-Transplant Treatment with Carfilzomib, Lenalidomide and Low dose Dexamethasone (CRd) in Transplant Candidates with Newly Diagnosed, Multiple Myeloma Requiring Systemic Chemotherapy
Description: This phase II trial studies how well carfilzomib, lenalidomide, and dexamethasone before and after stem cell transplant works in treating patients with newly diagnosed multiple myeloma....MORE
___________________________________________________________________________________________________
 Number: 201312090 Principal Investigator: Stockerl-Goldstein, Keith
Title: An Open-Label, Phase 2 Study to Evaluate the Oral Combination of MLN9708 With Cyclophosphamide and Dexamethasone In Patients With Newly Diagnosed Multiple Myeloma Requiring Systemic Treatment
Description: The main purpose of this study is to find out the effects, good and/or bad, the study drug (MLN9708),cyclophosphamide, and dexamethasone have on multiple myeloma when given together....MORE
___________________________________________________________________________________________________
 Number: 201308053 Principal Investigator: Vij, Ravi
Title: Phase 1/2 Clinical Trial of NPI-0052 in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma
Description: The purpose of this research study is to find out if an investigational drug known as marizomib (NPI-0052) has an effect on multiple myeloma....MORE
___________________________________________________________________________________________________
 Number: 201207063 Principal Investigator: Vij, Ravi
Title: A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects with Relapsed or Refractory Multiple Myeloma
Description: This study is designed to evaluate the effect of ABT-199 in subjects with Multiple Myeloma (MM) who have had their MM come back after treatment with currently available medications and therapies. The purpose of this study is to determine the safety, pharmacokinetics (how much ABT 199 is absorbed...MORE
___________________________________________________________________________________________________
 Number: 201201069 Principal Investigator: Vij, Ravi
Title: A Multicenter Phase 2 Study of the Bruton’s Tyrosine Kinase (Btk) Inhibitor, PCI-32765, in Subjects with Relapsed or Relapsed and Refractory Multiple Myeloma
Description: The purposes of this study include finding out if the study drug, given once daily by mouth, will slow or stop your cancer from getting worse, and whether the study drug has side effects....MORE
___________________________________________________________________________________________________
 Number: 201109172 Principal Investigator: Vij, Ravi
Title: Phase 1b/2, Multicenter, Open-label Study of the Safety and Activity of ONX 0912 in Patients with Hematological Malignancies
Description: The purpose of this study is to test the safety of an investigational new drug called ONX 0912 at different dose levels and to find out what effects it has on patients and their cancer....MORE
___________________________________________________________________________________________________
 Number: 201108186 Principal Investigator: Stockerl-Goldstein, Keith
Title: A Phase 3, Randomized Open Label Trial of Lenalidomide/dexamethasone With or Without Elotuzumab in Subjects with Previously Untreated Multiple Myeloma
Description: The purpose of this research study is to determine if an investigational drug called elotuzumab given with the standard drugs lenalidomide and dexamethasone is more effective in the initial treatment of multiple myeloma compared with a standard treatment of lenalidomide and dexamethasone alone. This...MORE
___________________________________________________________________________________________________
 Number: 201101815 Principal Investigator: Vij, Ravi
Title: Connect MM: The Multiple Myeloma disease Registry
Description: This research study is being done to learn more about multiple myeloma and its treatments. Researchers also want to better understand how multiple myeloma impacts the life of people living with multiple myeloma. This is an observational study, which means it is a study that does not prescribe...MORE
___________________________________________________________________________________________________
 Number: 201207060 Principal Investigator: Wildes, Tanya
Title: Pilot Study of Geriatric Assessments in Senior Adults with Multiple Myeloma
Description: The purpose of this research study is to evaluate the impact that treatments for multiple myeloma have on the quality of life of the older adult population. Current treatments for multiple myeloma have led to improved outcomes, but little research on the way treatment affects quality of life in old...MORE
___________________________________________________________________________________________________
 Number: 201210094 Principal Investigator: Vij, Ravi
Title: Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (Preamble)
Description: The purpose of this research study is to examine how multiple myeloma is treated by doctors all over the world, how patients respond to these treatments, and the economic impact of these treatments....MORE
___________________________________________________________________________________________________
 Number: 201102270 Principal Investigator: Vij, Ravi
Title: Tissue Acquisition for Analysis of Genetic Progression of Monoclonal Gammopathy of Unknown Significance and Multiple Myeloma
___________________________________________________________________________________________________
 Number: 201105191 Principal Investigator: Vij, Ravi
Title: Ancillary Tissue Collection Project: Collection of Multiple Myeloma Blood and Bone Marrow Aspirate (MMRC)
___________________________________________________________________________________________________